The independent source for health policy research, polling, and news.
301 - 320 of 330 Results
Former New York City Mayor Michael Bloomberg uses health care as a key message in his Democratic presidential primary run. Now that he will be taking the stage in the Feb. 19 debate, the message could take on even more prominence.
Across the U.S., people with early dementia are signing new advance directives to confirm their end-of-life wishes while they still have the ability to do so. But doctors say the documents may offer a false sense of security.
Suicide rates across the country have been rising for 20 years. That’s true in New York, too, but even so, its rate is about half that of the country as a whole.
A USC-Brookings analysis finds that the New York plan to resolve disputes between providers and insurers without leaving patients on the hook might actually be driving up costs in the system.
New York, where nearly 900 people contracted measles this year, has enacted contentious requirements for immunizations.
Under federal law, people who have been raped don’t have to pay for medical forensic exams, yet many get billed and have trouble getting the hospitals or collection agencies to stop dunning them for payment.
Despite what New York Mayor Bill de Blasio claimed during the first night of the presidential debates, universal health care in the Big Apple is still in the seeding stage.
Under a program enacted in Washington state this spring, workers can get up to $36,500 to help pay for long-term health care and services such as installing grab bars in the shower or respite care for family caregivers.
A large public hospital in Los Angeles gets over 1,000 unidentified patients a year. Most are quickly identified, but some require considerable gumshoe work — a task that can be complicated by medical privacy laws.
The pesticide chlorpyrifos has been linked to developmental problems in children. Some state and federal lawmakers want the chemical banned, but federal regulators are fighting to keep it on the market.
More than 275 people — mostly in Orthodox Jewish communities — have been infected since the disease began spreading in October. That’s about half of the confirmed cases in 11 states that were reported nationwide by the federal officials since January 2018.
As calls for "Medicare-for-all" grow louder among Democrats in Congress, Democratic governors and mayors have been pushing ahead with urgency to corral medical costs and bring health care to those who remain uninsured.
If a popular app used by many farmers markets to process federal supplemental nutrition assistance program (SNAP) benefits is no longer offered next spring, consumers’ access to fresh produce may be stalled.
Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
Supporters call it the strongest move yet to document a patient’s advance wishes in cases of severe dementia. Critics say it would deny basic care to society’s most vulnerable.
President Donald Trump’s decision to stop paying cost-sharing reduction subsidies means the federal government will reduce its funding of the Basic Health Program that provides low-cost coverage to more than 800,000 low-income people in those two states.
Refugee women from conservative Muslim countries can be shocked by some U.S. medical conventions — like trusting a male doctor to care for them.
A new law gives Medicaid regulators power to threaten drugmakers with cost-effectiveness scrutiny unless they grant additional rebates.
© 2026 KFF